Since we have shown that USP15 is essential for maintaining HBx stability and that USP15 augments HBx-mediated oncogenic signals, one inference from our work is that compromising USP15 might be a novel approach to abrogate cellular transformation and serve as a target for anti-cancer therapy. This evidence concerns the gene USP15 and cancer.